DIANE MITCHELL: Open Payments
NPI 1124035399 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 72 payments from 13 companies in 2025. Trend: 2023 $1,934 · 2024 $1,959 · 2025 $1,561
Food & beverage: $1,561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $374 |
| Madrigal Pharmaceuticals | 7 | $297 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $217 |
| Ardelyx, Inc. | 10 | $213 |
| Janssen Biotech, Inc. | 8 | $155 |
| Ipsen Biopharmaceuticals, Inc | 3 | $70 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| Gilead Sciences, Inc. | 2 | $43 |
| Aimmune Therapeutics, Inc. | 2 | $41 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
Products named: REZDIFFRA, XIFAXAN, IBSRELA, RINVOQ, TREMFYA, SKYRIZI, CREON, IQIRVO.
Industry payments across GA — which companies pay providers there.
